Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine

Netherlands Journal of Medicine

Volumn 46, Issue 1, 1995, Pages 4-14

  de Glas Vos, J W ^a   Krediet, R T ^a   Weening, J J ^a   Arisz, L ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Azathioprine; Intravenous methylprednisolone pulse therapy; Severe proliferative lupus nephritis

Indexed keywords

AZATHIOPRINE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; ORAL DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AZATHIOPRINE; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; INFUSIONS, INTRAVENOUS; LUPUS NEPHRITIS; MALE; METHYLPREDNISOLONE; MIDDLE AGED;

EID: 0028869563     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-2977(94)00085-N     Document Type: Article

References (36)

1. The natural history of the renal manifestations of systemic lupus erythematosus
2. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis
3. Lupus nephritis: clinical course as related to morphologic forms and their transitions
4. The clinical course of the proliferative and membranous forms of lupus nephritis
5. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis
6. Therapy of lupus nephritis
7. Longterm preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only
8. Controlled trial of pulse methylprednisolone versus two regimes of pulse cyclophosphamide in severe lupus nephritis
9. Long-term prognosis of diffuse lupus nephritis
10. Treatment of diffuse proliferative lupus nephritis
11. Some new aspects of lupus nephritis
12. Glomerulonephritis of systemic diseases - lupus nephritis
13. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome
14. Decreased filtration fraction during active proliferative lupus nephritis: relation to disease activity and reversibility of renal function
15. A radio-isotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow
16. Lupus nephritis
17. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death
18. The bimodal mortality pattern of systemic lupus erythematosus
19. Mortality in lupus nephritis
20. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population
21. Contribution of renal biopsy data in predicting outcome in lupus nephritis
22. Beneficial effects of methylprednisolone pulse therapy in diffuse proliferative lupus nephritis
23. Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis
24. Serum immune complexes and disease activity in lupus nephritis
25. Intravenous methylprednisolone pulses in diffuse proliferative lupus nephritis
26. Treatment of diffuse proliferative lupus nephritis by intravenous high-dose methylprednisolone
27. The treatment of lupus nephritis by methylprednisolone pulse therapy
28. High-dose intravenous methyl-prednisolone pulse therapy in systemic lupus erythematosus
29. Methylprednisolone pulse therapy for lupus nephritis: a follow-up study
30. Monthly pulses of methylprednisolone in SLE nephritis
31. Pulse methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis
32. Use of pulse methylprednisolone in primary and multisystem glomerular diseases
33. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis
34. Systemic lupus with nephritis: a long-term study
35. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy
36. Wegener granulomatosis an analysis of 158 patients